Harbin Gloria Pharmaceuticals Co.,Ltd.’s Net Profit Rose 618% in First Quarter of 2023

Harbin Gloria Pharmaceuticals Co.,Ltd. (哈尔滨誉衡药业股份有限公司) (002437.SZ) reported a net profit of 21.9 million yuan in the first quarter of 2023, up 618% year-on-year.

Meanwhile, the company posted 681.2 million yuan in revenue, down 12% year-on-year.

At the end of the reporting period, it had 3.9 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 56.6%.